Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4742675
Max Phase: Preclinical
Molecular Formula: C18H14ClNO2
Molecular Weight: 311.77
Molecule Type: Unknown
Associated Items:
ID: ALA4742675
Max Phase: Preclinical
Molecular Formula: C18H14ClNO2
Molecular Weight: 311.77
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)Nc1ccc(Oc2ccc(Cl)c3ccccc23)cc1
Standard InChI: InChI=1S/C18H14ClNO2/c1-12(21)20-13-6-8-14(9-7-13)22-18-11-10-17(19)15-4-2-3-5-16(15)18/h2-11H,1H3,(H,20,21)
Standard InChI Key: NGPQXUQHQLUWLR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 311.77 | Molecular Weight (Monoisotopic): 311.0713 | AlogP: 5.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.30 | CX LogD: 4.30 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.72 | Np Likeness Score: -1.08 |
1. Shinozuka T,Ito S,Kimura T,Izumi M,Wakabayashi K. (2021) Discovery of a Novel Class of ERRα Agonists., 12 (5.0): [PMID:34055231] [10.1021/acsmedchemlett.1c00100] |
Source(1):